ISMB seminars take place on Wednesdays during term time, providing staff and students with the opportunity to hear world class researchers speak.
The termly seminar series are organised around specific themes, and are co-ordinated jointly by the Research Department of Structural Molecular Biology at UCL and the Department of Biological Sciences, Birkbeck. All are welcome to attend.


Term 3/Summer 2021-22 Seminar Series
Immune Receptors in Health and Disease

(click above to view programme of talks)

Coordinators: Profs. Andrew Martin and Adrian Shepherd

Understanding B-cell receptor (antibody) and T-cell receptor repertoires has become a hugely important area of research, especially in the face of novel pandemics such as Covid-19. Changes in antibody repertoires and the classes of antibodies we produce with ageing are linked to disease susceptibility. In addition, antibody-based drugs now represent up to 1/3rd of drugs in development with over 100 approved for everything from cancer to high cholesterol and migraine and over 200 in development for Covid-10 alone. There are even over a dozen antibody-based drugs for use in cats and dogs that have reached the stage of being officially named. This seminar series will explore the research and application of these molecules in health and disease.

Previous ISMB seminars

2021-22 ISMB Special Event: Two Years of Covid-19
2021-22 Term 2/Spring series: Transcription-coupled processes: gene regulation, DNA repair and recombination in cells and viruses
2021-22 Term 1/Autumn series: RNA, the Multi-Faceted Regulator

2020-21 ISMB Special Event: Ancestry, Genetics and Race: Dealing with the Legacy of Scientific Racism
2020-21 Term 3/Summer series: Life at the single-molecule level: from DNA interactions to cell-level processes
2020-21 Term 2/Spring series: Understanding molecular machines: from mechanisms to health and disease
2020-21 Term 1/Autumn series: Redox regulation in health and disease

For further information about ISMB Seminars, please contact the ISMB administrator.